The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Reporting owner

Climaco John M

Reporting owner CIK 0001546797 · Chief Executive Officer · Director

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Climaco John MClimaco John MClimaco John M · November 17, 2025 · Stock award · Option to purchase common stockClimaco John M · November 12, 2025 · Stock award · Stock Options (right to buy)Nov 12, 2025Nov 17, 2025
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

2 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Nov 17, 2025CNS Pharmaceuticals, Inc.Option to purchase common stockClimaco John MStock award
Nov 12, 2025Moleculin Biotech, Inc.Stock Options (right to buy)Climaco John MStock award

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: CNS Pharmaceuticals, Inc.CNSP · company listings
Climaco John MChief Executive Officer · Director
Stock awardOption to purchase common stockDerivative security · Code A9,7610 *Value: 0Currency not specifiedView ↗
Trade: Moleculin Biotech, Inc.MBRX · company listingsStock awardStock Options (right to buy)Derivative security · Code A150,000Not reported *Value: Not reportedCurrency not specifiedView ↗